Works matching IS 09024441 AND DT 2021 AND VI 106 AND IP 3
Results: 18
Vitamin E and acute graft‐versus‐host disease after myeloablative allogeneic hematopoietic cell transplantation.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 417, doi. 10.1111/ejh.13567
- By:
- Publication type:
- Article
Matched sibling donor stem cell transplantation for sickle cell disease: Results from the Spanish group for bone marrow transplantation in children.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 408, doi. 10.1111/ejh.13566
- By:
- Publication type:
- Article
Higher average chemotherapy dose intensity improves prognosis in patients with aggressive adult T‐cell leukemia/lymphoma.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 398, doi. 10.1111/ejh.13565
- By:
- Publication type:
- Article
One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 389, doi. 10.1111/ejh.13564
- By:
- Publication type:
- Article
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 380, doi. 10.1111/ejh.13563
- By:
- Publication type:
- Article
The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 371, doi. 10.1111/ejh.13561
- By:
- Publication type:
- Article
Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 433, doi. 10.1111/ejh.13559
- By:
- Publication type:
- Article
The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 428, doi. 10.1111/ejh.13556
- By:
- Publication type:
- Article
Platelet transfusion and tranexamic acid to prevent bleeding in outpatients with a hematological disease: A Dutch nationwide survey.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 362, doi. 10.1111/ejh.13555
- By:
- Publication type:
- Article
Characterization and prognostic implication of delayed complete response in AL amyloidosis.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 354, doi. 10.1111/ejh.13554
- By:
- Publication type:
- Article
The hematologic consequences of obesity.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 306, doi. 10.1111/ejh.13560
- By:
- Publication type:
- Article
The impact of COVID‐19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single‐center experience.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 340, doi. 10.1111/ejh.13552
- By:
- Publication type:
- Article
Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 320, doi. 10.1111/ejh.13550
- By:
- Publication type:
- Article
A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre‐ibrutinib era.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 346, doi. 10.1111/ejh.13553
- By:
- Publication type:
- Article
A regulatory element in the 3′‐untranslated region of CEBPA is associated with myeloid/NK/T‐cell leukemia.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 327, doi. 10.1111/ejh.13551
- By:
- Publication type:
- Article
Current understanding and future implications of sepsis‐induced thrombocytopenia.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 301, doi. 10.1111/ejh.13549
- By:
- Publication type:
- Article
Prognostic models in chronic lymphocytic leukemia patients receiving ibrutinib therapy: Results of a comparative performance analysis.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 425, doi. 10.1111/ejh.13548
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 299, doi. 10.1111/ejh.13443
- Publication type:
- Article